Mohammed Bakkali

Dr. Mohammed Bakkali

Departamento de Genética, Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2016 in eLife
Verified
Journal Article
Open access
Francisco Javier Barrionuevo JimenezFrancisco Javier Barrionuevo Jimenez
Francisco Javier Barrionuevo Jimenez
AHAlicia Hurtado
Alicia Hurtado
GKGwang-Jin Kim
Gwang-Jin Kim
FRFrancisca M Real
Francisca M Real
MBMohammed Bakkali
Mohammed Bakkali
Rafael JiménezRafael Jiménez
Rafael Jiménez
The new concept of mammalian sex maintenance establishes that particular key genes must remain active in the differentiated gonads to avoid genetic sex reprogramming, as described in adult ovaries after Foxl2 ablation. Dmrt1 plays a similar role in postnatal testes, but the mechanism of adult testis maintenance remains mostly unknown. Sox9 and Sox8 are required for postnatal male fertility, but their role in the adult testis has not been investigated. Here we show that after ablation of Sox9 in Sertoli cells of adult, fertile Sox8-/- mice, testis-to-ovary genetic reprogramming occurs and Sertoli cells transdifferentiate into granulosa-like cells. The process of testis regression culminates in complete degeneration of the seminiferous tubules, which become acellular, empty spaces among the extant Leydig cells. DMRT1 protein only remains in non-mutant cells, showing that SOX9/8 maintain Dmrt1 expression in the adult testis. Also, Sox9/8 warrant testis integrity by controlling the expression of structural proteins and protecting Sertoli cells from early apoptosis. Concluding, this study shows that, in addition to its crucial role in testis development, Sox9, together with Sox8 and coordinately with Dmrt1, also controls adult testis maintenance.

5 December 2014 in Chromosoma
Verified
Journal Article
Closed access
PDF file
JCJuan Pedro M Camacho
Juan Pedro M Camacho
FRFrancisco J. Ruíz-Ruano
Francisco J. Ruíz-Ruano
RMR. Martín-Blázquez
R. Martín-Blázquez
MLM. D. López-León
M. D. López-León
JCJ. Cabrero
J. Cabrero
MBMohammed Bakkali
Mohammed Bakkali

1 October 1999 in Heredity
Verified
Journal Article
Closed access
PDF file
JCJ Cabrero
J Cabrero
MLM D López-León
M D López-León
MBMohammed Bakkali
Mohammed Bakkali
JCJuan Pedro M Camacho
Juan Pedro M Camacho

11 November 2018 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
AHAgustín Hidalgo-Gutierrez
Agustín Hidalgo-Gutierrez
EBEliana Barriocanal‐Casado
Eliana Barriocanal‐Casado
MBMohammed Bakkali
Mohammed Bakkali
MDM. Elena Díaz-Casado
M. Elena Díaz-Casado
LSLaura Sánchez‐Maldonado
Laura Sánchez‐Maldonado
Luis LopezLuis Lopez
Luis Lopez
Coenzyme Q (CoQ) deficiency has been associated with primary defects in the CoQ biosynthetic pathway or to secondary events. In some cases, the exogenous CoQ supplementation has limited efficacy. In the Coq9 R239X mouse model with fatal mitochondrial encephalopathy due to CoQ deficiency, we have tested the therapeutic potential of β‐resorcylic acid (β‐RA), a structural analog of the CoQ precursor 4‐hydroxybenzoic acid and the anti‐inflammatory salicylic acid. β‐RA noticeably rescued the phenotypic, morphological, and histopathological signs of the encephalopathy, leading to a significant increase in the survival. Those effects were due to the decrease of the levels of demethoxyubiquinone‐9 (DMQ 9 ) and the increase of mitochondrial bioenergetics in peripheral tissues. However, neither CoQ biosynthesis nor mitochondrial function changed in the brain after the therapy, suggesting that some endocrine interactions may induce the reduction of the astrogliosis, spongiosis, and the secondary down‐regulation of astrocytes‐related neuroinflammatory genes. Because the therapeutic outcomes of β‐RA administration were superior to those after CoQ 10 supplementation, its use in the clinic should be considered in CoQ deficiencies.

1 August 2017 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Open access
ISIván Sánchez-Castro
Iván Sánchez-Castro
MRMiguel Angel Ruiz-Fresneda
Miguel Angel Ruiz-Fresneda
MBMohammed Bakkali
Mohammed Bakkali
PKPeter Kämpfer
Peter Kämpfer
SGStefanie P. Glaeser
Stefanie P. Glaeser
MMMohamed L. Merroun
Mohamed L. Merroun
A Gram-stain negative, rod-shaped, aerobic bacterial strain, BII-R7T, was isolated during a study targeting the culture-dependent microbial diversity occurring in bentonite formations from southern Spain. Comparative 16S rRNA gene sequence analysis showed that BII-R7T represented a member of the genus Stenotrophomonas (class Gammaproteobacteria ), and was related most closely to Stenotrophomonas rhizophila e-p10T (99.2 % sequence similarity), followed by Stenotrophomonas pavanii ICB 89T (98.5 %), Stenotrophomonas maltophilia IAM 12423T, Stenotrophomonas chelatiphaga LPM-5T and Stenotrophomonas tumulicola T5916-2-1bT (all 98.3 %). Pairwise sequence similarities to all other type strains of species of the genus Stenotrophomonas were below 98 %. Genome-based calculations (orthologous average nucleotide identity, original average nucleotide identity, genome-to-genome distance and DNA G+C percentage) indicated clearly that the isolate represents a novel species within this genus. Different phenotypic analyses, such as the detection of a quinone system composed of the major compound ubiquinone Q-8 and a fatty acid profile with iso-C15 : 0 and anteiso-C15 : 0 as major components, supported this finding at the same time as contributing to a comprehensive characterization of BII-R7T. Based on this polyphasic approach comprising phenotypic and genotypic/molecular characterization, BII-R7T can be differentiated clearly from its phylogenetic neighbours, establishing a novel species for which the name Stenotrophomonas bentonitica sp. nov. is proposed with BII-R7T as the type strain (=LMG 29893T=CECT 9180T=DSM 103927T).

5 February 2013 in Archives of Microbiology
Verified
Journal Article
Open access
PDF file
MBMohammed Bakkali
Mohammed Bakkali
DNA acquisition promotes the spread of resistance to antibiotics and virulence among bacteria. It is also linked to several natural phenomena including recombination, genome dynamics, adaptation and speciation. Horizontal DNA transfer between bacteria occurs via conjugation, transduction or competence for natural transformation by DNA uptake. Among these, competence is the only mechanism of transformation initiated and entirely controlled by the chromosome of the recipient bacteria. While the molecular mechanisms allowing the uptake of extracellular DNA are increasingly characterized, the function of competence for natural transformation by DNA uptake, the selective advantage maintaining it and the reasons why bacteria take up DNA in the first place are still debated. In this synthesis, I review some of the literature and discuss the four hypotheses on how and why do bacteria take up DNA. I argue that DNA uptake by bacteria is an accidental by-product of bacterial adhesion and twitching motility. Adhesion and motility are generally increased in stressful conditions, which may explain why bacteria increase DNA uptake in these conditions. In addition to its fundamental scientific relevance, the new hypothesis suggested here has significant clinical implications and finds further support from the fact that antibiotics sometimes fail to eliminate the targeted bacterium while inevitably causing stress to others. The widespread misuse of antibiotics may thus not only be selecting for resistant strains, but may also be causing bacteria to take up more DNA with the consequent increase in the chances of acquiring drug resistance and virulence—a scenario in full concordance with the previously reported induction of competence genes by antibiotics in Streptococcus pneumoniae and Legionella pneumophila.